Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement
In conclusion, although HM did not adversely impact in-hospital mortality or major complications following TAVR, it was linked to modestly increased resource utilization and readmission. Patients with prior stem cell transplantation represent a particularly vulnerable subgroup, underscoring the need for multidisciplinary pre-operative evaluation and specialized perioperative care pathways.
Authors
- Radoslav Zinoviev (ORCID: https://orcid.org/0000-0002-0619-426X)
- Peyman Benharash (ORCID: https://orcid.org/0000-0002-4705-0262)
- Giselle Porter (ORCID: https://orcid.org/0000-0002-3040-460X)
- Esteban Aguayo
- Zeyu Liu (ORCID: https://orcid.org/0000-0003-4377-1780)
- Konmal Ali
Institutions
- University of California, Los Angeles (US)
- Core Laboratories (United States) (US)
Publication Details
- Journal
- Clinics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.clinsp.2025.100741
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00